Scientists at Queensland University of Technology (QUT), funded by Cancer Council Queensland, are conducting research into the deadliest form of ovarian cancer. [ + ]

Calzada (ASX:CZD) subsidiary Metabolic has secured the first of what it hopes will be a number of licensing agreements with Australian compounding pharmacies for its peptide drug AOD9604. [ + ]

IDT Australia (ASX:IDT) is evaluating acquiring Perrigo's US ANDA filing for a synthetic oestrogen product, as it seeks to expand its specialty generic drug portfolio. [ + ]

AusBiotech calls on industry leaders (CEOs and MDs) to respond to the annual Biotechnology Industry Position Survey 2014 in order to contribute to the annual snapshot and build the advocacy platform for the year to come. [ + ]

A new tool that guides catheter placement is being taken up by Australian hospitals. [ + ]

The dream of sequencing an entire human genome for $1000 has become a reality. [ + ]

A US jury has found Cochlear (ASX:COH) liable of patent infringement and awarded damages of US$131.2m, but the company has vowed to appeal. [ + ]

The 2014 winners of the Australian Academy of Science's prestigious annual awards for scientific excellence have been announced. [ + ]

iSonea (ASX:ISN) has picked up a Tech Podcast Network award for its asthma symptom monitoring tools AirSonea and AsthmaSense Prime. [ + ]

Immuron (ASX:IMC) has commenced a $9.6m capital raising, for purposes including raising funds for upcoming phase IIb trial of IMM-124E in NASH. [ + ]

The study of crystallography - the only technique for examining the arrangement and structure of matter or materials at the atomic or molecular level - is around 100 years old. In light of this, the United Nations Educational, Scientific and Cultural Organisation (UNESCO) has declared 2014 the International Year of Crystallography (IYCr2014). [ + ]

The federal government has resumed a review on Employee Share Schemes that had paused pre-election when the government entered caretaker mode. Submissions that were lodged previously with the government will be considered as part of this consultation process and new submissions will be accepted now. [ + ]

The genome of the hookworm, the most common soil-transmitted parasitic worm, has been sequenced. [ + ]

Global stem cell manufacturer Lonza has agreed to produce the stocks of Regeneus' (ASX:RGS) cell therapy CryoShot Canine for an upcoming US marketing study. [ + ]

Sanofi Pasteur has signed a vaccine development agreement with the University of Melbourne. The alliance was facilitated by UoM Commercial, the university's commercial engagement services company. [ + ]